Jean Francois Formela, Director at Korro Bio, Inc. (KRRO), sold 171,405 shares at $13.95 ($2.5M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($2.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.95 | 580 | $8K | 0.3% |
| 2 | $13.95 | 3,382 | $47K | 1.9% |
| 3 | $14.25 | 17,426 | $248K | 10.1% |
| 4 | $14.25 | 101,579 | $1.4M | 58.9% |
| 5 | $14.60 | 40,679 | $594K | 24.2% |
| 6 | $14.60 | 6,979 |
| $102K |
| 4.1% |
| 7 | $14.98 | 114 | $2K | 0.1% |
| 8 | $14.98 | 666 | $10K | 0.4% |
| Total | $14.34 avg | 171,405 | $2.5M | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |